You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A BIOMATERIAL FOR ESOPHAGEAL REPAIR

    SBC: ACELL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): ACell is a tissue engineering company and its core technology is based upon a porcine derived extracellular matrix (ECM) harvested from the urinary bladder (UBM) that serves as a constructive scaffold for tissue reconstruction. Successful completion of Phase I studies showed that the UBM-ECM can be configured into a tube shaped device with mechanical and materi ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  2. HUMAN MONOCOLONAL ANTIBODIES FOR CNS REMYELINATION

    SBC: Acorda Therapeutics, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The primary goal of the current research will be to select the best recombinant form of one of two naturally occurring human igM antibodies demonstrated to stimulate remyelination to further develop for clinical testing in inflammatory demyelinating disease, such as MS. These antibodies, designated sHIgM22 and sHIgM46, were isolated by the Rodriquez laboratory ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  3. HIGH PERFORMANCE DETECTOR FOR SMALL ANIMAL PET

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant):Positron Emission Tomography (PET) is an in vivo analog of autoradiography, which makes it a potentially powerful new tool for imaging biological processes and molecular targets in small laboratory animals. Its fundamental advantage is that functional data can be obtained non-invasively, allowing each animal to be studied repeatedly. Thus, each animal can serve ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  4. HYBRID APD/ASIC DETECTOR MODULE FOR SMALL ANIMAL PET

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant):The proposed Phase II research focuses upon an application specific integrated circuit (ASIC) that is necessary to support new avalanche photodiode (APD) and lutetium orthosilicate (LSO) detector module designed for small-animal PET applications. Based on our Phase I experience, advanced research and development will be carried out to design and fabricate a soph ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  5. A NEW FAST HIGH RESOLUTION SCINTILLATOR FOR PET AND CT

    SBC: RADIATION MONITORING DEVICES, INC.            Topic: N/A

    Not Avaialble

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  6. REDUCING HYPERACTIVITY WITH A FEEDBACK ACTIGRAPH

    SBC: AMBULATORY MONITORING, INC.            Topic: N/A

    This application addresses the need for an alternative to pharmacological treatment of children diagnosed with ADHD (and other conditions that may present motoric excess). Technological enhancements to the Phase I Feedback Actigraph, now referred to as BuzzBee¿, will allow multiple activity recorders (belt-worn by ADHD diagnosed children) equipped with vibrotactile, auditory, and visual feedback ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  7. SF/HGF GENE TRANSFER FOR PERIPHERAL ISCHEMIA

    SBC: Angion Biomedica Corp.            Topic: N/A

    Cardiovascular disease is the leading cause of morbidity and mortality in the US, afflicting over 58 million Americans. Angiogenic factors can increase vascularization and improve perfusion in ischemia. Scatter factor/hepatocyte growth factor (SF/HGF) may be superior to other angiogenic factors because of multiple actions on components of the angiogenic cascade and anti-apoptotic properties. Our P ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  8. SUPERFLUIDS ISOLATION OF NATURAL ANTI-CANCER DRUGS

    SBC: APHIOS CORPORATION            Topic: N/A

    N/A

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  9. ENHANCED CALIBRATION PHANTOM FOR ULTRASOUND IMAGING

    SBC: APPLIED COATINGS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Efforts will be made to produce Thin Film Phantom systems that enables the precise placement of sub-resolvable 'digital scatterers' on a acoustically transparent supporting media in a tissue mimicking fluid. Research will include not only the continued study on tissue mimicking material, supporting medium, and materials for digital scatterers but expanding app ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  10. DEVELOPMENT OF A BIOLOGICALLY-ACTIVE VASCULAR GRAFT

    SBC: BIOMOD SURFACES            Topic: N/A

    Medium (6-8mm) and small (

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government